4.7 Article

Mass Spectrometric Characterization of Human N-Acylethanolamine-hydrolyzing Acid Amidase

Journal

JOURNAL OF PROTEOME RESEARCH
Volume 11, Issue 2, Pages 972-981

Publisher

AMER CHEMICAL SOC
DOI: 10.1021/pr200735a

Keywords

endocannabinoid; glycosylation; lysosomal enzyme; mannose-6-phosphate; N-acylethanolamine; N-acylethanolamine-hydrolyzing acid amidase (NAAA); N-terminal nucleophile hydrolase; palmitoylethanolamine (PEA)

Funding

  1. National Institutes of Health/National Institute on Drug Abuse [DA003801, DA007312, DA009158]

Ask authors/readers for more resources

N-Acylethanolamine-hydrolyzing acid amidase (NAAA) is a lysosomal enzyme that primarily degrades palmitoylethanolamine (PEA), a lipid amide that inhibits inflammatory responses. We developed a HEK293 cell line stably expressing the NAAA pro-enzyme (zymogen) and a single step chromatographic purification of the protein from the media. Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry MALDI-TOF MS analysis of the zymogen(47.7 kDa) treated with peptide-N-glycosidase F (PNGase F) identified 4 glycosylation sites, and acid cleavage of the zymogen into alpha- and beta-subunits (14.6 and 33.3 kDa) activated the enzyme. Size exclusion chromatography estimated the mass of the active enzyme as 45 +/- 3 kDa, suggesting formation of an alpha/beta heterodimer. MALDI-TOF MS fingerprinting covered more than 80% of the amino acid sequence, including the N-terminal peptides, and evidence for the lack of a disulfide bond between subunits. The significance of the cysteine residues was established by their selective alkylation resulting in almost complete loss of activity. The purified enzyme was kinetically characterized with PEA and a novel fluorogenic substrate, N-(4-methyl coumarin) palmitamide (PAMCA). The production of sufficient quantities of NAAA and a high throughput assay could be useful in discovering novel inhibitors and determining the structure and function of this enzyme.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Anesthesiology

N-acylethanolamine-hydrolysing acid amidase: A new potential target to treat paclitaxel-induced neuropathy

Wisam Toma, Martial Caillaud, Nipa H. Patel, Tammy H. Tran, Giulia Donvito, Jane Roberts, Deniz Bagdas, Asti Jackson, Aron Lichtman, David A. Gewirtz, Alexandros Makriyannis, Michael S. Malamas, M. Imad Damaj

Summary: The study shows that paclitaxel reduces PEA levels in the spinal cord, while exogenous administration of PEA partially alleviates PIPN. Additionally, targeting NAAA enzyme with specific compound AM9053 can reverse and prevent PIPN. These findings suggest that selective NAAA inhibitors could be promising future therapeutics for the treatment and prevention of PIPN.

EUROPEAN JOURNAL OF PAIN (2021)

Article Nursing

Maternal Dietary Fatty Acids and Their Relationship to Derived Endocannabinoids in Human Milk

Adriana V. Gaitan, JodiAnne T. Wood, Yingpeng Liu, Lipin Ji, Spyros P. Nikas, Alexandros Makriyannis, Carol J. Lammi-Keefe

Summary: This study found correlations between maternal dietary intake of long-chain polyunsaturated fatty acids and the concentrations of fatty acids and derived endocannabinoids in human milk. The inadequate intake of docosahexaenoic acid by participants was highlighted as a concern for infant development.

JOURNAL OF HUMAN LACTATION (2021)

Article Biochemistry & Molecular Biology

Interference with TGFβ1-Mediated Inflammation and Fibrosis Underlies Reno-Protective Effects of the CB1 Receptor Neutral Antagonists AM6545 and AM4113 in a Rat Model of Metabolic Syndrome

Basma G. Eid, Thikryat Neamatallah, Abeer Hanafy, Hany M. El-Bassossy, Lenah Binmahfouz, Hibah M. Aldawsari, Atif Hasan, Gamal Abd El-Aziz, Kiran Vemuri, Alexandros Makriyannis

Summary: The study investigated the effects of two neutral CB1 receptor antagonists, AM6545 and AM4113, on nephropathy associated with MetS in rats. Both compounds showed renal protective effects by inhibiting elevated proteinuria and albumin excretion rate, alleviating swelling and inflammatory cells infiltration in kidney structures, and preventing urine uric acid increase, collagen deposition, and elevated expression of TGF beta 1 in MetS animals. AM6545 and AM4113 interfered with TGF beta 1-mediated renal inflammation and fibrosis through peripheral action.

MOLECULES (2021)

Article Neurosciences

The endocannabinoid 2-arachidonoylglycerol and dual ABHD6/MAGL enzyme inhibitors display neuroprotective and anti-inflammatory actions in the in vivo retinal model of AMPA excitotoxicity

Despina Kokona, Dimitris Spyridakos, Manolis Tzatzarakis, Sofia Papadogkonaki, Eirini Filidou, Konstantinos Arvanitidis, George Kolios, Manjunath Lamani, Alexandros Makriyannis, Michael S. Malamas, Kyriaki Thermos

Summary: The endocannabinoid 2-AG has shown neuroprotective effects against excitotoxicity in the retina by activating CB1 and CB2 receptors as well as the PI3K/Akt signaling pathway. Inhibition of its metabolic enzymes, such as ABHD6 and MAGL, also provides partial neuroprotection against excitotoxicity in the retina.

NEUROPHARMACOLOGY (2021)

Article Chemistry, Medicinal

Oxa-adamantyl cannabinoids

Thanh C. Ho, Marcus A. Tius, Spyros P. Nikas, Ngan K. Tran, Fei Tong, Han Zhou, Nikolai Zvonok, Alexandros Makriyannis

Summary: The novel oxa-adamantyl cannabinoids are identified as high affinity ligands for CB1 and CB2 cannabinoid receptors, showing potential as potent CB1 receptor agonists. Their synthesis is convenient, amenable to scale up, and suitable for large-scale preparation.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2021)

Article Chemistry, Medicinal

Novel Functionalized Cannabinoid Receptor Probes: Development of Exceptionally Potent Agonists

Shan Jiang, Christos Iliopoulos-Tsoutsouvas, Fei Tong, Christina A. Brust, Catherine M. Keenan, Jimit Girish Raghav, Tian Hua, Simiao Wu, Jo-Hao Ho, Yiran Wu, Travis W. Grim, Nikolai Zvonok, Ganesh A. Thakur, Zhi-Jie Liu, Keith A. Sharkey, Laura M. Bohn, Spyros P. Nikas, Alexandros Makriyannis

Summary: Novel cannabinergic probes have been developed to stabilize cannabinoid receptors through tight binding interactions, exhibiting high binding affinity and potent agonist activity. A key ligand, 27a, displays exceptional megagonist properties, acting centrally and peripherally, distinguishing it from previously reported megagonists.

JOURNAL OF MEDICINAL CHEMISTRY (2021)

Article Biochemistry & Molecular Biology

1-, 2-and 3-AG as substrates of the endocannabinoid enzymes and endogenous ligands of the cannabinoid receptor 1

Shrouq I. Farah, Samantha Hilston, Ngan Tran, Nikolai Zvonok, Alexandros Makriyannis

Summary: The interaction profiles of 2-AG, 1-AG, and 3-AG with endocannabinoid enzymes and CB1 receptor show differences in affinity and potency. The stereochemistry is crucial for the MGL enzyme, with 3-AG being the best substrate and 1-AG demonstrating the worst substrate profile. Both 1-AG and 3-AG are efficiently hydrolyzed by hABHD6 without preference.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2022)

Article Neurosciences

Peripherally administered cannabinoid receptor 2 (CB2R) agonists lose anti-allodynic effects in TRPV1 knockout mice, while intrathecal administration leads to anti-allodynia and reduced GFAP, CCL2 and TRPV1 expression in the dorsal spinal cord and DRG

Jenny L. Wilkerson, Lauren B. Alberti, Ganesh A. Thakur, Alexandros Makriyannis, Erin D. Milligan

Summary: CB2R agonists can impact the expression of TRPV1 in the spinal cord and DRG, critical for combating allodynia.

BRAIN RESEARCH (2022)

Article Pharmacology & Pharmacy

N-Acylethanolamine acid amidase (NAAA) is dysregulated in colorectal cancer patients and its inhibition reduces experimental cancer growth

Barbara Romano, Ester Pagano, Fabio A. Iannotti, Fabiana Piscitelli, Vincenzo Brancaleone, Giuseppe Lucariello, Maria Francesca Nani, Ferdinando Fiorino, Rosa Sparaco, Giovanna Vanacore, Federica Di Tella, Donatella Cicia, Ruggero Lionetti, Alexandros Makriyannis, Michael Malamas, Marcello De Luca, Giovanni Aprea, Maria D'Armiento, Raffaele Capasso, Bernardo Sbarro, Tommaso Venneri, Vincenzo Di Marzo, Francesca Borrelli, Angelo A. Izzo

Summary: The research shows the functional importance of N-acyl ethanolamine acid amidase (NAAA) in colorectal cancer (CRC) progression, with its inhibition counteracting tumor growth and affecting the composition of tumor secretome. NAAA is proposed as a valid drug target for the treatment of CRC growth and development.

BRITISH JOURNAL OF PHARMACOLOGY (2022)

Article Chemistry, Medicinal

Improved cyclobutyl nabilone analogs as potent CB1 receptor agonists

Ioannis P. Papanastasiou, Markos-Orestis Georgiadis, Christos Iliopoulos-Tsoutsouvas, Carol A. Paronis, Christina A. Brust, Ngan K. Tran, Lipin Ji, Xiaoyu Ma, JodiAnne T. Wood, Nikolai Zvonok, Fei Tong, Laura M. Bohn, Spyros P. Nikas, Alexandros Makriyannis

Summary: This study merged the features of nabilone and AM2389 and optimized the C3 side chain. Among the nabilone analogs, AM8936 exhibited balanced and potent agonist activity on the CB1 receptor, making it a potential candidate for further development.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2022)

Article Multidisciplinary Sciences

Synthon-based ligand discovery in virtual libraries of over 11 billion compounds

Arman A. Sadybekov, Anastasiia Sadybekov, Yongfeng Liu, Christos Iliopoulos-Tsoutsouvas, Xi-Ping Huang, Julie Pickett, Blake Houser, Nilkanth Patel, Ngan K. Tran, Fei Tong, Nikolai Zvonok, Manish K. Jain, Olena Savych, Dmytro S. Radchenko, Spyros P. Nikas, Nicos A. Petasis, Yurii S. Moroz, Bryan L. Roth, Alexandros Makriyannis, Vsevolod Katritch

Summary: Structure-based virtual ligand screening using V-SYNTHES method is effective in rapidly identifying high-scoring compounds from a large chemical space, with experimental results demonstrating successful hit rates and potencies. This approach shows promise for lead discovery and is easily scalable for use with diverse docking algorithms.

NATURE (2022)

Article Anesthesiology

A peripheral CB2 cannabinoid receptor mechanism suppresses chemotherapy-induced peripheral neuropathy: evidence from a CB2 reporter mouse

Xiaoyan Lin, Zhili Xu, Lawrence Carey, Julian Romero, Alexandros Makriyannis, Cecilia J. Hillard, Elizabeth Ruggiero, Marilyn Dockum, George Houk, Ken Mackie, Phillip J. Albrecht, Frank L. Rice, Andrea G. Hohmann

Summary: This study investigated the cell types expressing CB2 receptor and found that CB2 expressed in previously unrecognized populations of skin cells may serve as a potential target for suppressing chemotherapy-induced neuropathic pain.
Article Multidisciplinary Sciences

Inhibition of triple negative breast cancer-associated inflammation, tumor growth and brain colonization by targeting monoacylglycerol lipase

Othman Benchama, Sergiy Tyukhtenko, Michael S. Malamas, Mark K. Williams, Alexandros Makriyannis, Hava Karsenty Avraham

Summary: This study found that the use of MAGL inhibitor AM9928 can effectively block the adhesion and migration of TNBC cells, reduce the secretion of pro-inflammatory factors by cells, and inhibit the activation of HBMECs and cytokine secretion caused by TNBC. Animal experiments showed that AM9928 can inhibit the growth of mammary tumors in the mammary fat pads and reduce the permeability changes of the blood brain barrier, thus reducing the metastasis of TNBC in the brain. These findings suggest that MAGL inhibitors have the potential to be a novel strategy for TNBC treatment.

SCIENTIFIC REPORTS (2022)

Correction Chemistry, Medicinal

Oxa-adamantyl cannabinoids (vol 38, 127882, 2021)

Thanh C. Ho, Joseph J. Mullins, Marcus A. Tius, Spyros P. Nikas, Ngan K. Tran, Fei Tong, Nicolai Zvonok, Alexandros Makriyannis

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2022)

Article Cell Biology

PKC is an indispensable factor in promoting environmental toxin chromium-mediated transformation and drug resistance

Suthakar Ganapathy, Jian Liu, Tianqi Yu, Rui Xiong, Qiang Zhang, Alexandros Makriyannis, Changyan Chen

Summary: Hexavalent chromium (Cr(VI)) pollution is a serious environmental and health concern. This study reveals the role of protein kinase C (PKC) in Cr(VI)-induced carcinogenesis and drug resistance, and suggests that PKC can be a potential biomarker for early detection of health damages and a therapeutic target for developing new treatments for diseases caused by Cr(VI).

AGING-US (2022)

No Data Available